Francisco D. Ferrer - Publications

Risk factors for low humoral response to BNT-162b2 in hemodialysis patients.

Journal: Clinical nephrology

Published: October 02, 2023

Eculizumab discontinuation in a patient with atypical hemolytic uremic syndrome after ChAdOx1 nCoV-19 vaccination.

Journal: Clinical nephrology. Case studies

Published: November 21, 2022

Better Anti-Spike IgG Antibody Response to SARS-CoV-2 Vaccine in Patients on Haemodiafiltration than on Haemodialysis.

Journal: Blood purification

Published: May 04, 2022

Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections.

Journal: Blood purification

Published: February 04, 2022

Predictors of hyporesponsiveness to ESAs in peritoneal dialysis patients: the role of residual renal function.

Journal: Jornal brasileiro de nefrologia

Published: February 01, 2022

Milky effluent associated to lercanidipine in a peritoneal dialysis European patient.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: July 01, 2021

Humoral response to BNT162b2 mRNA COVID-19 vaccine in peritoneal and hemodialysis patients: A comparative study.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: June 22, 2021